Fluorinated analogues of ADAM as new PET radioligands for the serotonin transporter: Synthesis and pharmacological evaluation
✍ Scribed by Y. Huang; S.-A Bae; Z. Zhu; N. Guo; D.-R. Hwang; M. Laruelle
- Book ID
- 112132537
- Publisher
- John Wiley and Sons
- Year
- 2001
- Tongue
- French
- Weight
- 166 KB
- Volume
- 44
- Category
- Article
- ISSN
- 0022-2135
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract The serotoninergic system is involved in a variety of neurological and psychiatric disorders. Exploration of the serotonin transporters (5‐HTT) in living human brain by PET would be of great value for better understanding, diagnosis and therapeutic follow up of these diseases. In order
## Abstract Two novel radioligands for the serotonin transporter (SERT), [^125^I]{3‐[5‐iodo‐1‐[4‐fluorophenyl)‐1,3‐dihydroisobenzofuran‐1‐yl]‐propyl}‐dimethylamine ([^125^I]‐2) and __S__‐[^125^I]{3‐[5‐iodo‐1‐(4‐fluorophenyl)‐1,3‐dihydroisobenzofuran‐1‐yl]‐propyl}‐dimethylamine ([^125^I]‐(__S__)‐2)
We have synthesized new fluorine-18 labelled derivatives of thienylcyclohexylpiperidine (TCP), a non-competitive antagonist of NMDA receptor, which binds to the phencyclidine (PCP) binding site located within the receptor-associated ion channel. The mesylate precursors for (1S\* ,Z\*)-2-(hydroxymeth